Weighted Average Number of Shares Outstanding, Basic of Karyopharm Therapeutics Inc. from 2020 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and change rate from 2020 to Q3 2025.
  • Karyopharm Therapeutics Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 8.67K shares, a 4% increase year-over-year.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 122K shares, a 6.69% increase from 2023.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 114K shares, a 39.5% increase from 2022.
  • Karyopharm Therapeutics Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 81.9K shares.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

Karyopharm Therapeutics Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 8.67K +333 +4% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-03
Q2 2025 8.62K +551 +6.83% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 8.47K +770 +10% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-12
Q4 2024 122K +7.64K +6.69% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-19
Q3 2024 8.34K -106K -92.7% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-03
Q2 2024 8.07K -106K -92.9% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 7.7K -106K -93.2% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-12
Q4 2023 114K +32.4K +39.5% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-19
Q3 2023 114K -80.1M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 114K -79.5M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 113K -77.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 81.9K Oct 1, 2022 Dec 31, 2022 10-K 2025-02-19
Q3 2022 80.2M* +4.75M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 79.7M* +4.46M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-02
Q1 2022 77.6M* Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q3 2021 75.5M* Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 75.2M* Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04

Karyopharm Therapeutics Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 122K +7.64K +6.69% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-19
2023 114K +32.4K +39.5% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-19
2022 81.9K -75.1M Jan 1, 2022 Dec 31, 2022 10-K 2025-02-19
2021 75.2M* +3.17M Jan 1, 2021 Dec 31, 2021 10-K 2024-02-29
2020 72M* Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.